Open Internships

Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Hematology and Oncology are jointly recruiting a full-time advanced fellow at the Research Associate/Acting Instructor level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.

This is a year-long fellowship program with the goal of becoming an expert in BMT and immunotherapy. Rotations will include outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up, etc.) and immunotherapy services. The fellow will initially function as a primary provider with direct patient care responsibilities and will have increasing levels of clinical team leadership over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available for clinically focused research projects. 

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.

Anticipated start date: July 1, 2025

At the Fred Hutchinson Cancer Center (Fred Hutch), we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We are committed to increasing our awareness and improving our practices so that we are an organization known as a center of diversity and inclusion excellence.  As a part of this effort, we are committed to advancing diversity, equity, and inclusion in scientific research and supporting the career development of the next generation of scientists. 

Overview:

Fred Hutch is seeking applications for the 7th Annual Dr. Eddie Méndez Scholar Award, which recognizes outstanding postdoctoral fellows from any discipline conducting research on cancer, infectious diseases, or basic science. The award was created to recognize Dr. Méndez’s commitment to cancer research and supporting early-career scientists from historically excluded backgrounds. This award aims to build a community between postdoctoral scholars seeking academic faculty careers and scientists at Fred Hutch.

This award recognizes the achievements of post-doctoral fellows from backgrounds that are underrepresented in science based on the NIH definition, which includes individuals from underrepresented racial and ethnic groups (Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders), individuals with disabilities, and individuals from disadvantaged backgrounds. We acknowledge that not all groups historically excluded from science are within the NIH definition and have expanded eligibility to also include scientists who are LGBTQ , formerly incarcerated, and more. A selection committee consisting of Fred Hutch faculty will select up to eight awardees. Fred Hutch will provide an honorarium to awardees, and Fred Hutch will cover all expenses related to travel and accommodations.

Awardees will present at a scientific symposium honoring Dr. Eddie Méndez and have the opportunity to meet with Fred Hutch faculty and senior leaders. We will hold this event in person on the Fred Hutch campus in Seattle in July 16-17^th 2025.

The aims of this award are to:

1.                Network with peer/near peers (the cohort) and Fred Hutch staff & faculty

2.                Share your science and have achievements recognized by the FH community

3.                Provide awardees with info about FH as a prospective faculty and/or open the door for future collaborations

Dr. Méndez, who died of cancer in 2018, specialized in treating head-and-neck cancer, an often disfiguring and debilitating disease. It was his mission to save lives and improve the well-being of cancer patients, whether through spearheading minimally invasive robotic surgery for these tumors (he was the first in Washington state to perform such surgery) or tirelessly developing new treatments in his laboratory at Fred Hutch.

Faculty of any discipline from the Fred Hutch or University of Washington (UW) may be proposed as mentors, but UW faculty who plan to mentor must co-mentor with a Fred Hutch faculty member. The project must be focused on a topic of biological interest, must involve a computational or mathematical component, and may include an experimental component. A laboratory trained scientist may satisfy the computational and mathematical requirement by including a training component in their proposal. Computationally strong candidates may include a laboratory training component as well. The research direction should reflect the interests and ideas of the applicant, although the final research proposal may be jointly designed; see Additional Information for more details on the application process and for a list of potential mentors.

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.

Please direct all questions to Ruby Mae San Pedro, Computational Biology Research Administrator.

Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) Department of Pediatrics, Division of Hematology Oncology are jointly recruiting a full-time Bone Marrow Transplant/Immunotherapy Fellow with an appointment as Acting Instructor in the Department of Pediatrics at the University of Washington School of Medicine. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.

The selected individual for the advertised position is expected to participate in a year-long fellowship program with the goal of becoming an expert in pediatric hematopoietic cell transplantation (HCT) and Immunotherapy. This position will rotate through outpatient HCT services (autologous and allogeneic transplant, immunotherapy, Long Term Follow Up) and on the inpatient transplant service initially as a primary care provider with increasing levels of independent patient care responsibility over the course of the year. Exposure to some of our unique clinical programs, including non-malignant transplantation, high risk leukemia, and survivorship, will be part of the learning experience as well. Approximately 60-75% of the year will be devoted to clinical activities with the remaining time available for the opportunity to participate in research projects, which will be determined based on identification of mentors and projects. University of Washington faculty engage in teaching, research, and service.

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.

Anticipated start date is July 1, 2025.